Results 61 to 70 of about 28,908 (154)

Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9336-9345, October 2026.
ABSTRACT Aims To evaluate whether initiation of amiodarone while receiving sulfonylurea is associated with an increased risk of severe hypoglycemia compared with the initiation of other antiarrhythmic agents (flecainide, sotalol, or propafenone) while receiving sulfonylurea. Materials and Methods We conducted a population‐based cohort study using South
Sungho Bea, Hyesung Lee, Young Min Cho, You‐Jung Choi, Ju‐Young Shin, Katsiaryna Bykov   +5 more
wiley   +1 more source

Activité antidiabétique des racines de Zizyphus mauritiana Lam (Rhamnaceae) et des feuilles de Zizyphus mucronata Willd (Rhamnaceae) chez le lapin

, 2019
Le diabète est une maladie endocrinienne qui touche 2% de la population mondiale. L’objectif du présent travail était d’évaluer l’activité antihyperglycémiante des extraits aqueux des écorces de racines de Zizyphus mauritiana et des feuilles de Zizyphus ...
Denou, Adama
core   +1 more source

Age of Type 1 Diabetes Onset and Dementia Risk: A Swedish Nationwide, Register‐Based Cohort Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9134-9142, October 2026.
ABSTRACT Aims Individuals with Type 1 diabetes are at a higher risk of dementia compared to individuals without diabetes. Younger age at Type 1 diabetes onset has been linked to an increased risk of cardiovascular disease and higher mortality. This study aimed to determine whether younger age at Type 1 diabetes onset was also associated with all‐cause ...
Milena Jancev, Björn Eliasson, Geert Jan Biessels, J. Hans DeVries, Erik H. Serné, Frank L. J. Visseren, Araz Rawshani, Aidin Rawshani, Tali Cukierman‐Yaffe, Naveed Sattar, Hertzel C. Gerstein, Thomas T. van Sloten   +11 more
wiley   +1 more source

Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real‐World National Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9633-9643, October 2026.
ABSTRACT Aims Evidence regarding the efficacy and safety of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in monogenic diabetes is limited. We evaluated real‐world metabolic, renal, and safety outcomes of SGLT2i therapy in adults with monogenic diabetes.
Estelle Audrain, Pierre Bel Lassen, Christine Bellanné‐Chantelot, Marie Christine Vantyghem, Hippolyte Dupuis, Tiphaine Vidal‐Trecan, Nicolas Chevalier, Danièle Dubois‐Laforgue, Sophie Lamothe, Camille Vatier, Orianne Villard, René Valéro, Claire Briet, Corinne Vigouroux, Cécile Ciangura, Chloé Amouyal   +15 more
wiley   +1 more source

Aperçu - Vingt ans de surveillance du diabète grâce au Système canadien de surveillance des maladies chroniques

Promotion de la santé et prévention des maladies chroniques au Canada, 2019
En 1999, le gouvernement du Canada, en collaboration avec les provinces et les territoires, met sur pied le Système national de surveillance du diabète (SNSD) afin de suivre l’évolution des taux de diabète au Canada.
Allana G. LeBlanc, Yong Jun Gao, Louise McRae, Catherine Pelletier   +3 more
doaj   +1 more source

Le diabète philosophe

Socio-anthropologie, 2014
The case of diabetes shows us how someone who is ill manages with worry and care in a daily life full of constraints, and how he acquires a certain wisdom beyond medical knowledge. Diabetes is also philosophical in as far as it is at the heart of Georges
Mélinée Schindler
doaj   +1 more source

Untersuchung von Anti‐Glykan‐Antikörpern und Erforschung ihres medizinischen Potenzials mithilfe synthetischer Glykane

Angewandte Chemie, Volume 138, Issue 39, 21 September 2026.
Anti‐Glykan‐Antikörper spielen sowohl bei Gesundheit als auch bei Krankheit eine wesentliche Rolle. Der Zugang zu neuartigen Glykanstrukturen ermöglicht Fortschritte bei der Antikörpercharakterisierung für die Entdeckung von Biomarkern, die Antikörperentwicklung und das Impfstoffdesign.
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source

Serum C1q as a Novel Predictive Biomarker for Postoperative Delirium After Acute Type A Aortic Dissection

Immunity, Inflammation and Disease, Volume 14, Issue 9, September 2026.
ABSTRACT Background This study aimed to evaluate the predictive value of C1q (complement activation regulatory factor) for the occurrence of postoperative delirium (POD) following surgery for acute aortic dissection. Methods We prospectively included patients undergoing surgery for aortic dissection. Serum levels of C1q were measured preoperatively and
Jianing Wang, Yi Jiang, Wenxue Liu, Yapeng Wang, Shan Lu, Jiawei Zhu, Xiujuan Cai, Yuhuan Tian, Yongqing Cheng, Dongjin Wang, Yunxing Xue   +10 more
wiley   +1 more source

Mieux traiter le diabète : combattre l’inertie et améliorer l’adhésion au traitement.

, 2010
Le diabète est une maladie chronique par excellence. Comme beaucoup d’autres maladies chroniques, le diabète, qu’il soit de type 1 ou plus encore de type 2, est d’origine complexe, combinant l’influence de facteurs génétiques et environnementaux. Le but
PHILIPS, Jean-Christophe, PAQUOT, Nicolas, SCHEEN, André   +2 more
core  

Impact of the Type of Continuous Insulin Administration on Metabolism in a Diabetic Rat Model

Journal of Diabetes Research, 2016
Exogenous insulin is the only treatment available for type 1 diabetic patients and is mostly administered by subcutaneous (SC) injection in a basal and bolus scheme using insulin pens (injection) or pumps (preimplanted SC catheter).
A. Schaschkow, C. Mura, S. Dal, A. Langlois, E. Seyfritz, C. Sookhareea, W. Bietiger, C. Peronet, N. Jeandidier, M. Pinget, S. Sigrist, E. Maillard   +11 more
doaj   +1 more source